NCT07876349Recruiting
EHR Intervention to Increase HBOC Genetic Testing
Electronic Health Record-based Implementation Strategies and Decision Support for Hereditary Breast and Ovarian Cancer (HBOC) Genetic Testing Among Heterogeneous Women (ELISABETH) Pragmatic Trial
Source: ClinicalTrials.gov · Last updated 15 Oct 2026
Brief summary (registry, in English)
The purpose of this research study is to test how well a new approach - using tools built into the electronic health record (EHR)- can help increase genetic testing for hereditary breast and ovarian cancer (HBOC) in women who have a family history that puts them at higher risk. The study will also look at what helps or gets in the way of using these tools in everyday clinical care. As part of this study, the investigators are also evaluating a website called RealRisks, which is designed to support patients in understanding their risk and making informed decisions about genetic testing. By studying how patients and primary care providers use this tool, the investigators hope to improve the way decision support tools are used to guide conversations and decisions about HBOC testing.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- First submitted
- 28 Sept 2026
- Start date
- 1 Sept 2026
- Primary completion date
- 28 Feb 2028
- Lead sponsor
- Columbia University
- Diseases
- Ovarian cancer
- NCT number
- NCT07876349
What you commit to
- Study type: Interventional
- Planned participants: 55
- From 1 Sept 2026 to the primary completion date, 28 Feb 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- \- Patients who previously participated in the development studies for RealRisks and BNAV.
Who the study is looking for
- Women, age 21-75 years
- Completed Six-Point Scale (SPS) family history screener with a score of 6 or higher.
- Seen in NewYork Presbyterian primary care clinic selected for pilot testing
- No personal history of breast or ovarian cancer
- No prior germline HBOC genetic testing
- English or Spanish-speaking
- Access to a smartphone, tablet, or computer
- Able to provide written, verbal, or online informed consent
Age in the registry: 21 years to 75 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Columbia University Irving Medical Center Coordinator of this site? Confirm its status | New York | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.